Thioureas

May 29, 2020

Final PROSPER Results Show XTANDI® (enzalutamide) Significantly Extends Overall Survival in Men with Non-Metastatic Castration-Resistant Prostate Cancer

May 27, 2020

ESSA Pharma to Present at Jefferies Virtual Healthcare Conference

May 13, 2020

ERLEADA® (apalutamide) Significantly Improved Overall Survival in Patients with Non-Metastatic Castration-Resistant Prostate Cancer

Feb 03, 2020

Janssen to Highlight Depth of Solid Tumor Portfolio at ASCO GU

Nov 25, 2019

Astellas Announces the Approval of XTANDI® (enzalutamide) by the China National Medical Products Administration (NMPA)

Oct 18, 2019

ESSA Announces Changes to its Board of Directors

Sep 19, 2019

ESSA to Present at Ladenburg Thalmann Healthcare Conference

Jul 31, 2019

ESSA Announces that the Scheme of Arrangement with Realm Therapeutics has become Effective

Jul 30, 2019

ESSA Announces Court Sanction of the Scheme of Arrangement with Realm Therapeutics

Jul 15, 2019

ESSA Expands Leadership Team by appointing Alessandra Cesano as Chief Medical Officer